
The Council of State Bioscience Associations (CSBA) Board of Directors submitted formal comments to the Office of Management and Budget (OMB) on the proposed rule Regulation for Federal Financial Assistance.
The Council of State Bioscience Associations (CSBA) released data analyzing the potential impact of various drug pricing proposals on patient access to lifesaving medicines, future biomedical innovation, and the economic health of the life sciences industry.
The Council of State Bioscience Associations (CSBA) today announced the election of new board members to its Board of Directors for the next two-year term (2022-2023). CSBA also announced new board leadership, including new Chair of the Board of Directors, Maria Thacker, President & CEO of Georgia Bio.